Discovering a novel dual specificity tyrosine-phosphorylation-regulated kinase 1A (DYRK1A) inhibitor and its impact on tau phosphorylation and amyloid-β formation.

MLA

Tu, Huang-Ju, et al. “Discovering a Novel Dual Specificity Tyrosine-Phosphorylation-Regulated Kinase 1A (DYRK1A) Inhibitor and Its Impact on Tau Phosphorylation and Amyloid-β Formation.” Journal of Enzyme Inhibition and Medicinal Chemistry, vol. 39, no. 1, Dec. 2024, p. 2418470. EBSCOhost, https://doi.org/10.1080/14756366.2024.2418470.

APA

Tu, H.-J., Chao, M.-W., Lee, C.-C., Peng, C.-S., Wu, Y.-W., Lin, T. E., Chang, Y.-W., Yen, S.-C., Hsu, K.-C., Pan, S.-L., & HuangFu, W.-C. (2024). Discovering a novel dual specificity tyrosine-phosphorylation-regulated kinase 1A (DYRK1A) inhibitor and its impact on tau phosphorylation and amyloid-β formation. Journal of Enzyme Inhibition and Medicinal Chemistry, 39(1), 2418470. https://doi.org/10.1080/14756366.2024.2418470

Chicago

Tu, Huang-Ju, Min-Wu Chao, Cheng-Chung Lee, Chao-Shiang Peng, Yi-Wen Wu, Tony Eight Lin, Yu-Wei Chang, et al. 2024. “Discovering a Novel Dual Specificity Tyrosine-Phosphorylation-Regulated Kinase 1A (DYRK1A) Inhibitor and Its Impact on Tau Phosphorylation and Amyloid-β Formation.” Journal of Enzyme Inhibition and Medicinal Chemistry 39 (1): 2418470. doi:10.1080/14756366.2024.2418470.